| 000 | 01782 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517020018.0 | ||
| 264 | 0 | _c20151221 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1757-4684 | ||
| 024 | 7 |
_a10.15252/emmm.201404757 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDevalla, Harsha D | |
| 245 | 0 | 0 |
_aAtrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. _h[electronic resource] |
| 260 |
_bEMBO molecular medicine _cApr 2015 |
||
| 300 |
_a394-410 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aG Protein-Coupled Inwardly-Rectifying Potassium Channels _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aHeart Atria _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKv1.5 Potassium Channel _xantagonists & inhibitors |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xmetabolism |
| 650 | 0 | 4 |
_aPluripotent Stem Cells _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 700 | 1 | _aSchwach, Verena | |
| 700 | 1 | _aFord, John W | |
| 700 | 1 | _aMilnes, James T | |
| 700 | 1 | _aEl-Haou, Said | |
| 700 | 1 | _aJackson, Claire | |
| 700 | 1 | _aGkatzis, Konstantinos | |
| 700 | 1 | _aElliott, David A | |
| 700 | 1 | _aChuva de Sousa Lopes, Susana M | |
| 700 | 1 | _aMummery, Christine L | |
| 700 | 1 | _aVerkerk, Arie O | |
| 700 | 1 | _aPassier, Robert | |
| 773 | 0 |
_tEMBO molecular medicine _gvol. 7 _gno. 4 _gp. 394-410 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.15252/emmm.201404757 _zAvailable from publisher's website |
| 999 |
_c24640950 _d24640950 |
||